Stockpolly
Search

Categories·Healthcare·Pharmaceuticals

Prescription Drugs

Medicines that can only be purchased with a doctor's prescription.

−0.33% today·87 stocks

Stocks

By market cap · 87 stocks

  1. 1Eli LillyLLYDeveloper of Mounjaro, Zepbound, and Foundayo$1.10T−0.18%
  2. 2Johnson & JohnsonJNJDeveloper of medicines and procedure-based medical technologies$645.95B+0.85%
  3. 3MerckMRKMaker of Keytruda, vaccines, and animal medicines$366.18B−0.82%
  4. 4Novartis (ADR)NVSDeveloper of focused innovative medicines$292.35B−0.54%
  5. 5AstraZeneca (ADR)AZNOncology-led developer of specialty medicines$252.33B−1.12%
  6. 6Novo Nordisk (ADR)NVOGLP-1 and insulin specialist$202.54B−1.43%
  7. 7PfizerPFEDeveloper of Eliquis, Prevnar and cancer medicines$159.36B−0.21%
  8. 8Vertex PharmaceuticalsVRTXDeveloper of CFTR modulators and specialty medicines$137.48B−1.07%
  9. 9Sanofi (ADR)SNYDeveloper of Dupixent-led medicines and vaccines$107.62B−0.04%
  10. 10McKessonMCKPharmaceutical distributor and specialty-care services provider$104.60B+0.39%
  11. 11GSK (ADR)GSKDeveloper of Shingrix, Nucala, and Trelegy$101.82B+1.11%
  12. 12RegeneronREGNMaker of Dupixent, EYLEA HD, and Libtayo$81.82B−1.69%
  13. 13CencoraCORGlobal pharmaceutical distribution and specialty-care services$62.65B+0.22%
  14. 14Takeda (ADR)TAKDeveloper of ENTYVIO and plasma-derived therapies$57.37B0.00%
  15. 15Teva (ADR)TEVAMaker of global generics and neuroscience medicines$42.44B−3.16%
  16. 16Royalty PharmaRPRXBuyer and funder of drug royalties$26.97B−1.73%
  17. 17ViatrisVTRSGlobal maker of established brands and generics$19.03B−3.26%
  18. 18Ascendis Pharma (ADR)ASNDTransCon medicines for rare endocrine disorders$15.40B−0.58%
  19. 19Corcept TherapeuticsCORTCortisol-modulation medicines for endocrine disease and cancer$12.31B−2.62%
  20. 20Dr. Reddy's Laboratories (ADR)RDYMaker of global generics and pharmaceutical ingredients$10.15B+0.16%
  21. 21AlkermesALKSNeuroscience medicines for addiction, psychiatry and sleep$7.95B−3.04%
  22. 22LiquidiaLQDAInhaled treprostinil specialist for pulmonary hypertension$6.02B−3.26%
  23. 23Amneal PharmaceuticalsAMRXManufacturer of generics, biosimilars, and specialty medicines$5.60B−2.61%
  24. 24Definium TherapeuticsDFTXDeveloper of lysergide and R(-)-MDMA medicines$5.44B−6.48%
  25. 25IndiviorINDVDeveloper of SUBLOCADE opioid-use-disorder treatment$4.35B−1.22%
  26. 26OrganonOGNWomen's health, biosimilars, and established medicines$3.61B0.00%
  27. 27Tarsus PharmaceuticalsTARSMaker of XDEMVY for Demodex blepharitis$3.09B−0.18%
  28. 28Supernus PharmaceuticalsSUPNDeveloper of ADHD, Parkinson’s, and postpartum depression medicines$2.54B−0.97%
  29. 29Trevi TherapeuticsTRVIHaduvio developer targeting chronic cough$2.38B−6.57%
  30. 30HUTCHMED (ADR)HCMTargeted cancer and immunology medicines$2.16B−0.36%
  31. 31ANI PharmaceuticalsANIPMaker of Cortrophin and niche generic drugs$1.66B−0.91%
  32. 32Eton PharmaceuticalsETONRare-disease therapy developer and commercializer$1.64B−4.60%
  33. 33Latigo BiotherapeuticsLTGODeveloper of non-opioid NaV1.8 pain medicines$1.46B−2.60%
  34. 34HarrowHROWOphthalmic medicines and compounding$1.39B−3.24%
  35. 35OmerosOMERComplement drug developer with YARTEMLEA launch$1.35B−3.43%
  36. 36MannKindMNKDInhaled insulin and cardiometabolic therapies$1.26B−2.71%
  37. 37OPKO HealthOPKBioReference diagnostics and biopharma operator$1.10B−1.00%
  38. 38Amphastar PharmaceuticalsAMPHMaker of complex generic and branded injectable drugs$970.5M+0.59%
  39. 39Achieve Life SciencesACHVDeveloper of cytisinicline for nicotine dependence$831.5M−0.86%
  40. 40Collegium PharmaceuticalCOLLADHD and pain medicines portfolio$822.2M−4.12%
  41. 41Gyre TherapeuticsGYREMaker of ETUARY, China's lung-fibrosis therapy$734.7M−1.20%
  42. 42Zevra TherapeuticsZVRADeveloper of rare-disease treatments for NPC and UCD$683.7M−2.45%
  43. 43Aquestive TherapeuticsAQSTPharmFilm developer for rescue medicines$629.8M−2.71%
  44. 44Relmada TherapeuticsRLMDDeveloper of bladder cancer and CNS therapies$454.2M−4.09%
  45. 45EyePointEYPTRetinal drug-delivery therapy developer$375.6M−3.35%
  46. 46DBV Technologies (ADR)DBVTDeveloper of the Viaskin Peanut Patch$323.9M−6.18%
  47. 47Clinuvel Pharmaceuticals (ADR)CUVLSCENESSE®-centered melanocortin drug developer$310.6M−9.01%
  48. 48Amarin (ADR)AMRNCommercializer of Vascepa cardiovascular therapy$288.9M−0.71%
  49. 49Anika TherapeuticsANIKHA orthopedics for OA pain$282.4M+1.75%
  50. 50Sol-Gel TechnologiesSLGLDeveloper of licensed and clinical dermatology treatments$224.9M−5.47%